APO Research
Talk to an analyst

APO RESEARCH · REPORT

Botulinum Toxin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Botulinum Toxin Injection Industry Growth and Trends Forecast to 2032

27 December 202594 pages

Choose your research edition.

Industry ResearchBotulinum Toxin Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Botulinum Toxin Injection Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Botulinum Toxin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botulinum Toxin Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Botulinum Toxin Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Botulinum Toxin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Botulinum Toxin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Botulinum Toxin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Botulinum Toxin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Botulinum Toxin Injection include LIBP, AbbVie, US World Meds, Merz Pharmaceuticals, Medytox, Ipsen, Hugel and Daewoong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Botulinum Toxin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Botulinum Toxin Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Botulinum Toxin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Botulinum Toxin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Botulinum Toxin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Botulinum Toxin Injection Market by Company

LIBP

AbbVie

US World Meds

Merz Pharmaceuticals

Medytox

Ipsen

Hugel

Daewoong

Botulinum Toxin Injection Segment by Type

100IU/Vial

50IU/Vial

Other

Botulinum Toxin Injection Segment by Application

Medical

Cosmetic

Botulinum Toxin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botulinum Toxin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botulinum Toxin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botulinum Toxin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Botulinum Toxin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Botulinum Toxin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100IU/Vial Table 2. Major Company of 50IU/Vial Table 3. Major Company of Other Table 4. Global Botulinum Toxin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Botulinum Toxin Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Botulinum Toxin Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Botulinum Toxin Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Botulinum Toxin Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Botulinum Toxin Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Botulinum Toxin Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Botulinum Toxin Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Botulinum Toxin Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Botulinum Toxin Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Botulinum Toxin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Botulinum Toxin Injection Industry Trends Table 26. Botulinum Toxin Injection Industry Drivers Table 27. Botulinum Toxin Injection Industry Opportunities and Challenges Table 28. Botulinum Toxin Injection Industry Restraints Table 29. Global Botulinum Toxin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Botulinum Toxin Injection Revenue Market Share by Company (2021-2026) Table 31. Global Botulinum Toxin Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Botulinum Toxin Injection Sales Share by Company (2021-2026) Table 33. Global Botulinum Toxin Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Botulinum Toxin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Botulinum Toxin Injection Major Company Production Sites and Headquarters Table 36. Global Botulinum Toxin Injection Company, Product Type & Application Table 37. Global Botulinum Toxin Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Botulinum Toxin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Botulinum Toxin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Botulinum Toxin Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Botulinum Toxin Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Botulinum Toxin Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Botulinum Toxin Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Botulinum Toxin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Botulinum Toxin Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Botulinum Toxin Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Botulinum Toxin Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Botulinum Toxin Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Botulinum Toxin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Botulinum Toxin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Botulinum Toxin Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Botulinum Toxin Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Botulinum Toxin Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Botulinum Toxin Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Botulinum Toxin Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Botulinum Toxin Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Botulinum Toxin Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Botulinum Toxin Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Botulinum Toxin Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Botulinum Toxin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. LIBP Company Information Table 73. LIBP Business Overview Table 74. LIBP Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. LIBP Botulinum Toxin Injection Product Portfolio Table 76. LIBP Recent Development Table 77. AbbVie Company Information Table 78. AbbVie Business Overview Table 79. AbbVie Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AbbVie Botulinum Toxin Injection Product Portfolio Table 81. AbbVie Recent Development Table 82. US World Meds Company Information Table 83. US World Meds Business Overview Table 84. US World Meds Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. US World Meds Botulinum Toxin Injection Product Portfolio Table 86. US World Meds Recent Development Table 87. Merz Pharmaceuticals Company Information Table 88. Merz Pharmaceuticals Business Overview Table 89. Merz Pharmaceuticals Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merz Pharmaceuticals Botulinum Toxin Injection Product Portfolio Table 91. Merz Pharmaceuticals Recent Development Table 92. Medytox Company Information Table 93. Medytox Business Overview Table 94. Medytox Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Medytox Botulinum Toxin Injection Product Portfolio Table 96. Medytox Recent Development Table 97. Ipsen Company Information Table 98. Ipsen Business Overview Table 99. Ipsen Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Ipsen Botulinum Toxin Injection Product Portfolio Table 101. Ipsen Recent Development Table 102. Hugel Company Information Table 103. Hugel Business Overview Table 104. Hugel Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hugel Botulinum Toxin Injection Product Portfolio Table 106. Hugel Recent Development Table 107. Daewoong Company Information Table 108. Daewoong Business Overview Table 109. Daewoong Botulinum Toxin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Daewoong Botulinum Toxin Injection Product Portfolio Table 111. Daewoong Recent Development Table 112. North America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Botulinum Toxin Injection Sales by Country (2021-2026) & (K Units) Table 114. North America Botulinum Toxin Injection Sales Market Share by Country (2021-2026) Table 115. North America Botulinum Toxin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Botulinum Toxin Injection Sales Market Share Forecast by Country (2027-2032) Table 117. North America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Botulinum Toxin Injection Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Botulinum Toxin Injection Market Share by Country (2021-2026) Table 120. North America Botulinum Toxin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Botulinum Toxin Injection Market Share Forecast by Country (2027-2032) Table 122. Europe Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Botulinum Toxin Injection Sales by Country (2021-2026) & (K Units) Table 124. Europe Botulinum Toxin Injection Sales Market Share by Country (2021-2026) Table 125. Europe Botulinum Toxin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Botulinum Toxin Injection Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Botulinum Toxin Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Botulinum Toxin Injection Market Share by Country (2021-2026) Table 130. Europe Botulinum Toxin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Botulinum Toxin Injection Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Botulinum Toxin Injection Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Botulinum Toxin Injection Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Botulinum Toxin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Botulinum Toxin Injection Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Botulinum Toxin Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Botulinum Toxin Injection Market Share by Country (2021-2026) Table 140. Asia-Pacific Botulinum Toxin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Botulinum Toxin Injection Market Share Forecast by Country (2027-2032) Table 142. Latin America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Botulinum Toxin Injection Sales by Country (2021-2026) & (K Units) Table 144. Latin America Botulinum Toxin Injection Sales Market Share by Country (2021-2026) Table 145. Latin America Botulinum Toxin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Botulinum Toxin Injection Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Botulinum Toxin Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Botulinum Toxin Injection Market Share by Country (2021-2026) Table 150. Latin America Botulinum Toxin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Botulinum Toxin Injection Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Botulinum Toxin Injection Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Botulinum Toxin Injection Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Botulinum Toxin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Botulinum Toxin Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Botulinum Toxin Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Botulinum Toxin Injection Market Share by Country (2021-2026) Table 160. Middle East and Africa Botulinum Toxin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Botulinum Toxin Injection Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Botulinum Toxin Injection Distributors List Table 165. Botulinum Toxin Injection Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Botulinum Toxin Injection Image Figure 2. Global Botulinum Toxin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botulinum Toxin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Botulinum Toxin Injection Sales (2021-2032) & (K Units) Figure 5. 100IU/Vial Image Figure 6. Global 100IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50IU/Vial Image Figure 8. Global 50IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Botulinum Toxin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Botulinum Toxin Injection Market Share by Type 2025 VS 2032 Figure 13. North America Botulinum Toxin Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Botulinum Toxin Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Botulinum Toxin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Botulinum Toxin Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Botulinum Toxin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Botulinum Toxin Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Botulinum Toxin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Botulinum Toxin Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Botulinum Toxin Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Botulinum Toxin Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Botulinum Toxin Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Medical Image Figure 26. Global Medical Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cosmetic Image Figure 28. Global Cosmetic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Botulinum Toxin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Botulinum Toxin Injection Market Share by Application 2025 VS 2032 Figure 31. North America Botulinum Toxin Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Botulinum Toxin Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Botulinum Toxin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Botulinum Toxin Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Botulinum Toxin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Botulinum Toxin Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Botulinum Toxin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Botulinum Toxin Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Botulinum Toxin Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Botulinum Toxin Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Botulinum Toxin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Botulinum Toxin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Botulinum Toxin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Botulinum Toxin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Botulinum Toxin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Botulinum Toxin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Botulinum Toxin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Botulinum Toxin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Botulinum Toxin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Botulinum Toxin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Botulinum Toxin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Botulinum Toxin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Botulinum Toxin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Botulinum Toxin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Botulinum Toxin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Botulinum Toxin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Botulinum Toxin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Botulinum Toxin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Botulinum Toxin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Botulinum Toxin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Botulinum Toxin Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Botulinum Toxin Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100IU/Vial
  • 50IU/Vial
  • Other
Applications
  • Medical
  • Cosmetic
Companies covered
  • LIBP
  • AbbVie
  • US World Meds
  • Merz Pharmaceuticals
  • Medytox
  • Ipsen
  • Hugel
  • Daewoong

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Botulinum Toxin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Botulinum Toxin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Botulinum Toxin Injection Market by Type
  6. 1.3.1 100IU/Vial
  7. 1.3.2 50IU/Vial
  8. 1.3.3 Other
  9. 1.4 Global Botulinum Toxin Injection Market Size by Type
  10. 1.4.1 Global Botulinum Toxin Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Botulinum Toxin Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Botulinum Toxin Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Botulinum Toxin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Botulinum Toxin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Botulinum Toxin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Botulinum Toxin Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Botulinum Toxin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Botulinum Toxin Injection Industry Trends
  2. 2.2 Botulinum Toxin Injection Industry Drivers
  3. 2.3 Botulinum Toxin Injection Industry Opportunities and Challenges
  4. 2.4 Botulinum Toxin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Botulinum Toxin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Botulinum Toxin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Botulinum Toxin Injection Price (2021-2026)
  4. 3.4 Global Botulinum Toxin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Botulinum Toxin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Botulinum Toxin Injection Company, Product Type & Application
  7. 3.7 Global Botulinum Toxin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Botulinum Toxin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Botulinum Toxin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Botulinum Toxin Injection Tier 1, Tier 2, and Tier 3
4 Botulinum Toxin Injection Regional Status and Outlook
  1. 4.1 Global Botulinum Toxin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Botulinum Toxin Injection Historic Market Size by Region
  3. 4.2.1 Global Botulinum Toxin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Botulinum Toxin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Botulinum Toxin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Botulinum Toxin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Botulinum Toxin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Botulinum Toxin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Botulinum Toxin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Botulinum Toxin Injection by Application
  1. 5.1 Botulinum Toxin Injection Market by Application
  2. 5.1.1 Medical
  3. 5.1.2 Cosmetic
  4. 5.2 Global Botulinum Toxin Injection Market Size by Application
  5. 5.2.1 Global Botulinum Toxin Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Botulinum Toxin Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Botulinum Toxin Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Botulinum Toxin Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Botulinum Toxin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Botulinum Toxin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Botulinum Toxin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Botulinum Toxin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 LIBP
  2. 6.1.1 LIBP Company Information
  3. 6.1.2 LIBP Business Overview
  4. 6.1.3 LIBP Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 LIBP Botulinum Toxin Injection Product Portfolio
  6. 6.1.5 LIBP Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Botulinum Toxin Injection Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 US World Meds
  14. 6.3.1 US World Meds Company Information
  15. 6.3.2 US World Meds Business Overview
  16. 6.3.3 US World Meds Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 US World Meds Botulinum Toxin Injection Product Portfolio
  18. 6.3.5 US World Meds Recent Developments
  19. 6.4 Merz Pharmaceuticals
  20. 6.4.1 Merz Pharmaceuticals Company Information
  21. 6.4.2 Merz Pharmaceuticals Business Overview
  22. 6.4.3 Merz Pharmaceuticals Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merz Pharmaceuticals Botulinum Toxin Injection Product Portfolio
  24. 6.4.5 Merz Pharmaceuticals Recent Developments
  25. 6.5 Medytox
  26. 6.5.1 Medytox Company Information
  27. 6.5.2 Medytox Business Overview
  28. 6.5.3 Medytox Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Medytox Botulinum Toxin Injection Product Portfolio
  30. 6.5.5 Medytox Recent Developments
  31. 6.6 Ipsen
  32. 6.6.1 Ipsen Company Information
  33. 6.6.2 Ipsen Business Overview
  34. 6.6.3 Ipsen Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ipsen Botulinum Toxin Injection Product Portfolio
  36. 6.6.5 Ipsen Recent Developments
  37. 6.7 Hugel
  38. 6.7.1 Hugel Company Information
  39. 6.7.2 Hugel Business Overview
  40. 6.7.3 Hugel Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hugel Botulinum Toxin Injection Product Portfolio
  42. 6.7.5 Hugel Recent Developments
  43. 6.8 Daewoong
  44. 6.8.1 Daewoong Company Information
  45. 6.8.2 Daewoong Business Overview
  46. 6.8.3 Daewoong Botulinum Toxin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Daewoong Botulinum Toxin Injection Product Portfolio
  48. 6.8.5 Daewoong Recent Developments
7 North America by Country
  1. 7.1 North America Botulinum Toxin Injection Sales by Country
  2. 7.1.1 North America Botulinum Toxin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Botulinum Toxin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Botulinum Toxin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Botulinum Toxin Injection Market Size by Country
  6. 7.2.1 North America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Botulinum Toxin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Botulinum Toxin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Botulinum Toxin Injection Sales by Country
  2. 8.1.1 Europe Botulinum Toxin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Botulinum Toxin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Botulinum Toxin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Botulinum Toxin Injection Market Size by Country
  6. 8.2.1 Europe Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Botulinum Toxin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Botulinum Toxin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Botulinum Toxin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Botulinum Toxin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Botulinum Toxin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Botulinum Toxin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Botulinum Toxin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Botulinum Toxin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Botulinum Toxin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Botulinum Toxin Injection Sales by Country
  2. 10.1.1 South America Botulinum Toxin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Botulinum Toxin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Botulinum Toxin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Botulinum Toxin Injection Market Size by Country
  6. 10.2.1 South America Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Botulinum Toxin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Botulinum Toxin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Botulinum Toxin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Botulinum Toxin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Botulinum Toxin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Botulinum Toxin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Botulinum Toxin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Botulinum Toxin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Botulinum Toxin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Botulinum Toxin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Botulinum Toxin Injection Value Chain Analysis
  2. 12.1.1 Botulinum Toxin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Botulinum Toxin Injection Production Mode & Process
  7. 12.2 Botulinum Toxin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Botulinum Toxin Injection Distributors
  10. 12.2.3 Botulinum Toxin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst